Fixit Medical secures £38.4k for catheter securement technology

Cingo developer Fixit Medical Ltd has secured £38.4k in a new funding round that values the London-based company at £2.5m. The allotment for this round took place on 15 April 2026, with the official filing completed on 6 May 2026.

Incorporated in April 2012, Fixit Medical focuses on the development of medical devices for catheter management. Its primary product, Cingo, is designed to provide secure fixation for drainage catheters. The device addresses the clinical challenge of inadequate securement, which can cause complications for patients and healthcare providers. The technology is intended to allow patients to engage in daily activities without the risk of catheter displacement.

The current valuation of £2.5m matches the valuation achieved during the company's previous funding round in July 2025, where it raised £25k. This follows a period of valuation increases in 2023. In January 2023, the company raised £50k at a valuation of £117.6k. By March 2023, a further £100k investment saw the company valuation rise to £500.7k.

Fixit Medical operates with a team of three employees. The company provides its solutions to a global market, serving both individual patients and healthcare institutions. Its work involves research and experimental development within the medical technology field to improve patient care standards.